Peter W. Hashim
Icahn School of Medicine at Mount Sinai
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Peter W. Hashim.
Allergy | 2018
Tali Czarnowicki; Helen He; Huei-Chi Wen; Peter W. Hashim; John K. Nia; Kunal Malik; Yeriel Estrada; Grace Kimmel; Mark Taliercio; James G. Krueger; Emma Guttman-Yassky
Characterizing blood profile of alopecia areata (AA) is important not only for treatment advancements, but also for possibly identifying peripheral biomarkers that will eliminate the need for scalp biopsies. We aimed to compare frequencies of skin homing (CLA+) vs systemic (CLA−) “polar” CD4+ and CD8+ and activated T‐cell subsets in AA vs atopic dermatitis (AD) and control blood.
The Journal of Allergy and Clinical Immunology | 2018
Teresa Song; Ana B Pavel; Huei-Chi Wen; Kunal Malik; Yeriel Estrada; Juana Gonzalez; Peter W. Hashim; John K. Nia; Danielle Baum; Grace Kimmel; Giselle Singer; James G. Krueger; Emma Guttman-Yassky
This study expands the current paradigm on AA cytokine profile in serum and scalp, identifying IL-15, and Th1 and Th2 serum cytokines that reflect both tissue activity and clinical disease severity.
Archive | 2018
Grace Kimmel; John K. Nia; Peter W. Hashim; Mark Lebwohl
Biologic agents are a relatively new class of medication that typically target specific parts of the immune system. These medications were originally developed for use in a variety of autoimmune and inflammatory conditions, for which they have had great success in treatment. In recent years, biologics have been tested as off-label treatments for a number of dermatologic diseases. More research, including larger scale clinical trials, will likely be necessary to confirm their efficacy in these conditions, as most of the data to date has come from case reports and small case series. However, they have shown promise in the treatment of many of these diseases, which often are refractory to currently available conventional therapies. We will review to date information of off-label uses of biologic and related systemic agents for the treatment of a number of dermatologic conditions in this chapter.
Journal of Psoriasis and Psoriatic Arthritis | 2016
Zachary Levy; Mark Taliercio; John K. Nia; Grace Kimmel; Peter W. Hashim
Inverse psoriasis, also known as intertriginous or flexural psoriasis, remains a challenging condition to treat. For decades, the mainstay therapy approach has been low-potency steroids for short durations due to the risk of cutaneous atrophy and striae. Other topical options include immunomodulators, vitamin D analogues, and tar-based products. In this paper, we review the literature on the treatment options available for inverse psoriasis.
Global Dermatology | 2016
Linden Li; Mark Taliercio; Peter W. Hashim; Grace Kimmel; John K. Nia
Palmoplantar psoriasis is a chronic autoimmune disease characterized by the rise of desquamative plaques on the palms and soles. Due to the thick stratum corneum of the palmoplantar regions, the search for effective topical treatments has been significantly more difficult than other forms of psoriasis. Current topical treatments include phototherapy, methotrexate gel, laser therapy, and tazarotene ointment; most treatments outside of phototherapy, however, do not have sufficient high-level clinical evaluations to justify their efficacy. In this systematic review, we explore the literature on different topical treatment regimens for palmoplantar psoriasis. Correspondence to: John K Nia, Department of Dermatology, Icahn School of Medicine at Mount Sinai Medical Center, 5 E. 98th Street, New York, NY 10029, USA, Tel: 212-241-3288; Fax: 212-876-8961; E-mail: [email protected] Received: September 15, 2016; Accepted: October 13, 2016; Published: October 17, 2016 Li L (2016) Palmoplantar Psoriasis: a review of topical therapies Glob Dermatol, 2016 doi: 10.15761/GOD.1000196 Volume 3(6): 387-393 and were used to find other sources.
Archives of Dermatological Research | 2018
Emma Guttman-Yassky; John K. Nia; Peter W. Hashim; Yasaman Mansouri; Erisa Alia; Mark Taliercio; Parth N. Desai; Mark Lebwohl
SKIN The Journal of Cutaneous Medicine | 2018
Jerry Bagel; John K. Nia; Peter W. Hashim; Manmath Patekar; Ana de Vera; Sophie Hugot; Kuan Sheng; Summer Xia; Elsa Muscianisi; Andrew Blauvelt; Mark Lebwohl
Dermatologic Therapy | 2018
Jerry Bagel; John K. Nia; Peter W. Hashim; Manmath Patekar; Ana de Vera; Sophie Hugot; Kuan Sheng; Summer Xia; Isabelle Gilloteau; Elisa Muscianisi; Andrew Blauvelt; Mark Lebwohl
/data/revues/00916749/unassign/S0091674918309928/ | 2018
Teresa Song; Ana B Pavel; Huei-Chi Wen; Kunal Malik; Yeriel Estrada; Juana Gonzalez; Peter W. Hashim; John K. Nia; Danielle Baum; Grace Kimmel; Giselle Singer; James G Krueger; Emma Guttman-Yassky
Current Dermatology Reports | 2017
John K. Nia; Peter W. Hashim; Grace Kimmel; Ahmad I. Aleisa; Ariana C. Farahani; Mark Lebwohl